Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
'Orange Skies': Biden Raising Federal Pay to Fight Wildfires
The Biden administration says it is hiring more federal firefighters — and immediately raising their pay — as officials ramp up response efforts in the face of a severe drought that's setting the stage for another destructive summer of intense wildfires across the West.
How Human Stampedes Really Happen
Human stampedes have been a chronically understudied topic and there's been an uptick in reported crushes as populations have increased.
Load More